Melanie Chisam
Medical · Springfield, MONPI 1225136542
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (34.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 96.4% of it on its own, with 34 other manufacturers making up the rest. Among medical clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 350 payments — averaging $263.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$89K
- AstraZeneca$565
- Jazz Pharmaceuticals Inc.$326
- United Therapeutics Corporation$229
- Harmony Biosciences LLC$163
- Grifols USA, LLC$162
- plus $2K from 29 others
What the payments were for
- Consulting fees$31,95035%
- Speaking & faculty fees$30,00032%
- Travel & lodging$18,00219%
- Food & beverage$12,18713%
- Education$2000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 191 | $89,001 |
| AstraZeneca | 34 | $565 |
| Jazz Pharmaceuticals Inc. | 9 | $326 |
| United Therapeutics Corporation | 11 | $229 |
| Harmony Biosciences LLC | 5 | $163 |
| Grifols USA, LLC | 9 | $162 |
| GSK | 9 | $161 |
| Actelion Pharmaceuticals US, Inc. | 5 | $130 |
| CSL Behring | 6 | $127 |
| Novo Nordisk | 1 | $125 |
| Merck | 6 | $124 |
| AbbVie | 6 | $117 |
| Insmed, Inc. | 4 | $95 |
| ANI Pharmaceuticals, Inc. | 4 | $88 |
| Boehringer Ingelheim | 4 | $85 |
| Idorsia Pharmaceuticals US Inc | 5 | $82 |
| Mallinckrodt Hospital Products Inc. | 4 | $77 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $77 |
| Mylan Specialty L.p. | 5 | $72 |
| Amgen | 4 | $68 |
| Pfizer | 4 | $66 |
| Baxter Healthcare | 3 | $66 |
| Novartis | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Medtronic | 2 | $35 |
| Philips North America LLC | 2 | $33 |
| Johnson & Johnson | 1 | $31 |
| Genentech USA, Inc. | 2 | $28 |
| ZOLL Respicardia, Inc. | 1 | $20 |
| Resmed Corp | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Siemens Medical Solutions USA, Inc. | 1 | $17 |
| Viatris Specialty LLC | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$79,763
- Inspire Upper Airway Stimulation System$4,729
- Wegovy$125
How this compares
$92,339 in reported general payments places this provider in the 95th percentile of 198 medical providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EvrysdiRisdiplam | 12 | $322,708 |
| WakixPitolisant Hcl | 12 | $182,894 |
| Spiriva RespimatTiotropium Bromide | 28 | $21,270 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $21,134 |
| NeuproRotigotine | 13 | $10,780 |
| Armodafinil | 56 | $6,608 |
| BelsomraSuvorexant | 12 | $5,219 |
| Incruse ElliptaUmeclidinium Bromide | 13 | $4,599 |
| Qvar RedihalerBeclomethasone Dipropionate | 12 | $2,638 |
| Doxepin Hcl | 91 | $2,042 |
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 16 | $1,438 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 60 | $756 |
| Modafinil | 20 | $625 |
| Ipratropium Bromide | 22 | $616 |
| Zolpidem Tartrate ErZolpidem Tartrate | 18 | $485 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Genentech USA, Inc.Evrysdi | $28 | $322,70812 claims |
| Harmony Biosciences LLCWakix | $163 | $182,89412 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $161 | $25,73334 claims |
| Boehringer IngelheimSpiriva Respimat | $85 | $21,27028 claims |
| MerckBelsomra | $124 | $5,21912 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $13 | $2,63812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 198 medical providers in Missouri.
Other medical in Springfield
- Dustin BartlettSpringfield$21K
- Alina CumminsSpringfield$6K
- Amberly EversoleSpringfield$4K
- Kara WalkerSpringfield$4K
- Amber BeckSpringfield$2K
- Kaitlin FosterSpringfield$2K
- Jessica SpencerSpringfield$1K
- Emily JensenBowling Green$51K
- Sarah WilmsmeyerChesterfield$22K
- Amy MosmanSaint Louis$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.